Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 7/20 | 0.62 |
| ▸ | HTR1A | P08908 | 5/20 | 0.62 |
| ▸ | HTR2C | P28335 | 4/20 | 0.62 |
| ▸ | HTR2B | P41595 | 3/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | HTR6 | P50406 | 4/20 | 0.55 |
| ▸ | HTR1B | P28222 | 3/20 | 0.54 |
| ▸ | HTR7 | P34969 | 3/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.54 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.54 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N,N-Dimethyltryptamine SCHEMBL22736730 | 0.90 | HTR2A (0.71) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL25174555 | 0.88 | HTR2A (0.65) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL30483455 | 0.88 | MEN1 (0.57) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL30448862 | 0.88 | MEN1 (0.57) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL25256369 | 0.86 | HTR2A (0.79) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL30483443 | 0.81 | MEN1 (0.57) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL25204923 | 0.81 | HTR2A (0.66) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL30483454 | 0.81 | HTR2A (0.58) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL22736733 | 0.81 | HTR2A (0.77) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL22736734 | 0.78 | MEN1 (0.65) | HTR2AHTR1AHTR2CHTR2BSLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704806-A1 | INJECTABLE PHARMACEUTICAL FORMULATIONS | Cybin IRL Limited (IE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4654967-A1 | TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS BY PARENTERAL ADMINISTRATION OF A SINGLE, EFFECTIVE PARENTERAL DOSE OF A SHORT-ACTING PSYCHEDELIC AGENT | Cybin UK Ltd (GB) | 2025-12-03 | — | — | EP | disclosed |
| EP-4601639-A1 | METHOD OF ADMINISTRATION OF A PARENTERAL FORMULATION COMPRISING A PSYCHEDELIC AGENT | Cybin UK Ltd (GB) | 2025-08-20 | — | — | EP | disclosed |
| WO-2024251807-A1 | COMPANION ANIMAL TREATMENTS | CYBIN IRL LIMITED (IE) | 2024-12-12 | — | — | WO | disclosed |
| WO-2024231331-A1 | INJECTABLE PHARMACEUTICAL FORMULATIONS | CYBIN IRL LIMITED (IE) | 2024-11-14 | — | — | WO | disclosed |
| WO-2024156713-A1 | TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS BY PARENTERAL ADMINISTRATION OF A SINGLE, EFFECTIVE PARENTERAL DOSE OF A SHORT-ACTING PSYCHEDELIC AGENT | CYBIN UK LTD (GB) | 2024-08-02 | — | — | WO | disclosed |